Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522

The Journal of Urology
Yoichi MizutaniTsuneharu Miki

Abstract

Cyclooxygenase-2 (COX-2) is a key inducible enzyme involved in the production of prostaglandins and its inhibitors have been shown to induce apoptosis in various cancer cells. Several anticancer agents also mediate apoptosis and may share the common intracellular pathways leading to apoptosis with COX-2 inhibitors. We reasoned that combination treatment of bladder cancer cells with COX-2 inhibitors and anticancer agents may result in synergistic apoptosis. We examined whether the selective COX-2 inhibitor JTE-522 (4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide) synergizes with anticancer agents in cytotoxicity and apoptosis against bladder cancer cells in vitro and in vivo. Cytotoxicity was determined by the microculture tetrazolium dye assay. Combination treatment of T24 bladder cancer cells with JTE-522 and cis-diamminedichloroplatinum (II) (CDDP) resulted in a synergistic cytotoxic effect. Synergy achieved in cytotoxicity with JTE-522 and CDDP was shown to be due to apoptosis. Treatment of T24 cells with JTE-522 decreased expression of the anti-apoptotic molecule Bcl-2. The in vivo significant growth inhibitory effect of JTE-522 and CDDP against the T24 line heterotransplanted in SCID mice was also observed....Continue Reading

References

Apr 15, 1994·Cancer·J F KerrB V Harmon
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J L MasferrerK Seibert
Oct 28, 1998·Journal of the National Cancer Institute·M M Taketo
Nov 12, 1998·Journal of the National Cancer Institute·M M Taketo
Dec 30, 1998·Japanese Journal of Pharmacology·K WakitaniM Matsushita
Jun 17, 1999·Nature Medicine·K SeibertP Needleman
Nov 4, 2000·Science·L ZhangB Vogelstein
Aug 11, 2001·The New England Journal of Medicine·G A FitzGerald, C Patrono

❮ Previous
Next ❯

Citations

Jul 25, 2009·Cancer Chemotherapy and Pharmacology·Shawna N GreeneDeborah W Knapp
Nov 1, 2007·Expert Opinion on Investigational Drugs·Konstantinos GiannitsasPetros Perimenis
Mar 31, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·T NaruseN Ishiguro
Mar 6, 2007·Critical Reviews in Oncology/hematology·David J Stewart
May 10, 2007·The British Journal of Dermatology·C UlrichC Termeer
Mar 6, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Wei Zhong LiYan Qing Ding
Sep 2, 2006·Critical Reviews in Oncology/hematology·D J A de GrootS de Jong
Nov 12, 2010·International Journal of Radiation Biology·Krista A van NifterikJohannes Van Rijn
Oct 2, 2014·International Journal of Oral and Maxillofacial Surgery·Y YamashitaM Goto
Jun 30, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I DuranM Niroumand
Apr 3, 2013·Molecular Medicine Reports·Wenzhong QueJunmin Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis